Published in Am J Physiol Heart Circ Physiol on May 20, 2011
Differential modulation of nitric oxide synthases in aging: therapeutic opportunities. Front Physiol (2012) 1.04
Protective vascular and cardiac effects of inducible nitric oxide synthase in mice with hyperhomocysteinemia. PLoS One (2014) 0.76
Impact of Superoxide Dismutase Mimetic AEOL 10150 on the Endothelin System of Fischer 344 Rats. PLoS One (2016) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
The L-arginine-nitric oxide pathway. N Engl J Med (1993) 14.38
Nitric oxide and macrophage function. Annu Rev Immunol (1997) 12.77
The protective effects of estrogen on the cardiovascular system. N Engl J Med (1999) 6.25
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 4.91
COX-2-derived prostacyclin confers atheroprotection on female mice. Science (2004) 2.87
Vascular actions of estrogens: functional implications. Pharmacol Rev (2008) 2.52
Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science (2002) 2.45
Assessment of hemostatic risk factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol (2005) 2.45
Rat model of arterial thrombosis induced by ferric chloride. Thromb Res (1990) 2.32
Regulation of the expression of inducible nitric oxide synthase. Biol Chem (2003) 2.24
Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med (1997) 2.24
Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res (2002) 2.05
Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation (2001) 1.63
In vivo thrombus formation in murine models. Circ Res (2007) 1.54
Inducible nitric oxide synthase gene deletion exaggerates MAPK-mediated cyclooxygenase-2 induction by inflammatory stimuli. Am J Physiol Heart Circ Physiol (2010) 1.46
Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide. J Immunol (1994) 1.43
An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. Thromb Res (2005) 1.43
Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol (2000) 1.43
Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci U S A (1996) 1.40
Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest (1996) 1.35
Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase. J Biol Chem (2000) 1.32
Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation (1998) 1.29
17beta-estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase. Stroke (2002) 1.26
Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life. J Clin Invest (2002) 1.13
Blockade of AT1 receptor partially restores vasoreactivity, NOS expression, and superoxide levels in cerebral and carotid arteries of hindlimb unweighting rats. J Appl Physiol (1985) (2008) 1.02
Review of cardiovascular risk factors in women. Gend Med (2009) 1.01
Transendothelial migration of ferric ion in FeCl3 injured murine common carotid artery. Thromb Res (2005) 1.01
Women and smokers have elevated urinary F(2)-isoprostane metabolites: a novel extraction and LC-MS methodology. Lipids (2008) 1.00
Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue. Am J Physiol (1998) 0.97
Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the Risk of Arterial Thrombosis in relation to Oral contraceptives (RATIO) case-control study. Circulation (2010) 0.96
Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice. Am J Physiol Regul Integr Comp Physiol (2003) 0.95
17 beta-Estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS. Am J Physiol (1998) 0.95
Profound biopterin oxidation and protein tyrosine nitration in tissues of ApoE-null mice on an atherogenic diet: contribution of inducible nitric oxide synthase. Am J Physiol Heart Circ Physiol (2007) 0.94
Effect of estrogen on cerebrovascular prostaglandins is amplified in mice with dysfunctional NOS. Am J Physiol Heart Circ Physiol (2004) 0.90
Potentiation of oxygen-glucose deprivation-induced neuronal death after induction of iNOS. Stroke (1996) 0.89
Regulation of prostaglandin H2 synthase activity by nitrogen oxides. Biochemistry (1999) 0.87
Inducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid production. Am J Pathol (2006) 0.86
Oxidative alterations of cyclooxygenase during atherogenesis. Prostaglandins Other Lipid Mediat (2006) 0.84
Heart rate dynamics in iNOS knockout mice. Life Sci (2006) 0.83
Tissue factor and thrombosis models. Arterioscler Thromb Vasc Biol (2010) 0.83
Micro ATR-FTIR spectroscopic imaging of atherosclerosis: an investigation of the contribution of inducible nitric oxide synthase to lesion composition in ApoE-null mice. Analyst (2009) 0.82
Inhibitory signaling of 17β-estradiol in platelet activation: the pivotal role of cyclic AMP-mediated nitric oxide synthase activation. Eur J Pharmacol (2010) 0.78
Current status of thrombolytics-the need for better, especially safer, agents. Thromb Res (2008) 0.77
Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science (2003) 10.22
Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature (2009) 8.09
Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science (2003) 7.75
The proapoptotic factors Bax and Bak regulate T Cell proliferation through control of endoplasmic reticulum Ca(2+) homeostasis. Immunity (2007) 4.74
Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J Immunol (2002) 3.96
Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells. J Exp Med (2007) 3.67
The perivascular niche regulates breast tumour dormancy. Nat Cell Biol (2013) 3.36
An all-silicon passive optical diode. Science (2011) 3.36
A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J Biol Chem (2002) 3.17
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell (2013) 3.13
Molecular mechanisms of fibrinolysis. Br J Haematol (2005) 3.03
Recent immune status determines the source of antigens that drive homeostatic T cell expansion. J Immunol (2005) 2.73
Generation of CD8 T cell memory is regulated by IL-12. J Immunol (2007) 2.69
Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J Clin Invest (2004) 2.45
TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell (2008) 2.26
Enhanced T cell responses due to diacylglycerol kinase zeta deficiency. Nat Immunol (2003) 1.98
Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells. J Immunol (2006) 1.88
IL-15 regulates CD8+ T cell contraction during primary infection. J Immunol (2006) 1.88
Selective depletion of nonspecific T cells during the early stage of immune responses to infection. J Immunol (2003) 1.84
Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection. J Immunol (2003) 1.83
Inflammation in atherosclerosis and implications for therapy. Circulation (2004) 1.71
Clonal competition inhibits the proliferation and differentiation of adoptively transferred TCR transgenic CD4 T cells in response to infection. J Immunol (2006) 1.69
An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface. J Biol Chem (2004) 1.68
Innate and adaptive immune responses to Listeria monocytogenes: a short overview. Microbes Infect (2007) 1.68
Adaptor protein-3 in dendritic cells facilitates phagosomal toll-like receptor signaling and antigen presentation to CD4(+) T cells. Immunity (2012) 1.59
Cutting edge: homeostatic proliferation of peripheral T lymphocytes is regulated by clonal competition. J Immunol (2003) 1.55
An essential role of Th1 responses and interferon gamma in infection-mediated suppression of neoplastic growth. Cancer Biol Ther (2003) 1.52
Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes. Blood (2013) 1.48
Annexin II: a plasminogen-plasminogen activator co-receptor. Front Biosci (2002) 1.47
Inducible nitric oxide synthase gene deletion exaggerates MAPK-mediated cyclooxygenase-2 induction by inflammatory stimuli. Am J Physiol Heart Circ Physiol (2010) 1.46
Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke. J Cereb Blood Flow Metab (2010) 1.44
Functional plasticity in memory T helper cell responses. J Immunol (2007) 1.38
Size-dependent photoconductance in SnO2 nanowires. Small (2005) 1.34
Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood (2006) 1.34
Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages. Blood (2003) 1.32
Annexin A2 promotes glioma cell invasion and tumor progression. J Neurosci (2011) 1.23
Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11. J Biol Chem (2008) 1.22
Listeria monocytogenes as a vaccine vector: virulence attenuation or existing antivector immunity does not diminish therapeutic efficacy. J Immunol (2004) 1.22
Reduced apoptosis and ameliorated listeriosis in TRAIL-null mice. J Immunol (2004) 1.21
Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice. J Immunol (2007) 1.20
Functional characterization of MHC class II-restricted CD8+CD4- and CD8-CD4- T cell responses to infection in CD4-/- mice. J Immunol (2004) 1.19
Quantitative super-resolution imaging uncovers reactivity patterns on single nanocatalysts. Nat Nanotechnol (2012) 1.19
CD8+ T-cell memory: only the good ones last. Curr Opin Immunol (2004) 1.18
Cutting edge: chromatin remodeling as a molecular basis for the enhanced functionality of memory CD8 T cells. J Immunol (2008) 1.16
Bordetella type III secretion and adenylate cyclase toxin synergize to drive dendritic cells into a semimature state. J Immunol (2004) 1.15
Inflammation at the molecular interface of atherogenesis: an anthropological journey. Am J Pathol (2008) 1.15
The annexin A2 system and vascular homeostasis. Vascul Pharmacol (2011) 1.14
Single-molecule fluorescence imaging of nanocatalytic processes. Chem Soc Rev (2010) 1.14
Behavioral migration diversity of the Yangtze River Japanese Eel, Anguilla japonica, based on otolith Sr/Ca ratios. Dongwuxue Yanjiu (2011) 1.14
CD36, oxidized LDL and PPAR gamma: pathological interactions in macrophages and atherosclerosis. Vascul Pharmacol (2004) 1.13
Bordetella type III secretion modulates dendritic cell migration resulting in immunosuppression and bacterial persistence. J Immunol (2005) 1.13
Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood (2009) 1.13
OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells. J Immunol (2008) 1.12
Carbon monoxide and biliverdin prevent endothelial cell sloughing in rats with type I diabetes. Free Radic Biol Med (2006) 1.08
Quick to remember, slow to forget: rapid recall responses of memory CD8+ T cells. Cell Res (2009) 1.06
Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein. Virology (2005) 1.05
Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women. Breast Cancer Res (2012) 1.05
Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. J Clin Invest (2009) 1.04
Annexin A2 is a natural extrahepatic inhibitor of the PCSK9-induced LDL receptor degradation. PLoS One (2012) 1.04
Limited expansion of virus-specific CD8 T cells in the aged environment. Mech Ageing Dev (2009) 1.04
Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104). Circulation (2004) 1.03
Ordered iron oxide nanotube arrays of controlled geometry and tunable magnetism by atomic layer deposition. J Am Chem Soc (2007) 1.02
Making sense of inflammation, epigenetics, and memory CD8+ T-cell differentiation in the context of infection. Immunol Rev (2006) 1.01
Effect of matrine on Kupffer cell activation in cold ischemia reperfusion injury of rat liver. World J Gastroenterol (2002) 1.01
Single-molecule catalysis mapping quantifies site-specific activity and uncovers radial activity gradient on single 2D nanocrystals. J Am Chem Soc (2013) 1.01
Dendritic cell expression of the signaling molecule TRAF6 is critical for gut microbiota-dependent immune tolerance. Immunity (2013) 1.00
Environmental and genetic factors associated with congenital microtia: a case-control study in Jiangsu, China, 2004 to 2007. Plast Reconstr Surg (2009) 0.99
Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina. Mol Biol Cell (2009) 0.99
Annexin A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to progastrin in mice and HEK-293 cells. Gastroenterology (2010) 0.98
Inhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol efflux. J Biol Chem (2009) 0.98
A novel role of IL-15 in early activation of memory CD8+ CTL after reinfection. J Immunol (2005) 0.98
Human β-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation. J Surg Res (2012) 0.98
Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy. Stroke (2010) 0.98
Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone. Am J Pathol (2009) 0.97
Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population. Breast Cancer Res Treat (2010) 0.97
A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge. Vaccine (2011) 0.97
Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2. J Biol Chem (2010) 0.96
Efficacy of recombinant annexin 2 for fibrinolytic therapy in a rat embolic stroke model: a magnetic resonance imaging study. Brain Res (2007) 0.96
Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis. Stroke (2010) 0.96
The annexin A2/S100A10 system in health and disease: emerging paradigms. J Biomed Biotechnol (2012) 0.96
Chronic immunodeficiency in mice lacking RasGRP1 results in CD4 T cell immune activation and exhaustion. J Immunol (2007) 0.96
Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoprotein. J Biol Chem (2002) 0.95
Protein 3-nitrotyrosine in complex biological samples: quantification by high-pressure liquid chromatography/electrochemical detection and emergence of proteomic approaches for unbiased identification of modification sites. Methods Enzymol (2008) 0.95
Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36. Circulation (2004) 0.95
Heme catalyzes tyrosine 385 nitration and inactivation of prostaglandin H2 synthase-1 by peroxynitrite. J Lipid Res (2006) 0.95
Profound biopterin oxidation and protein tyrosine nitration in tissues of ApoE-null mice on an atherogenic diet: contribution of inducible nitric oxide synthase. Am J Physiol Heart Circ Physiol (2007) 0.94
Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice. Blood (2011) 0.92
Memory CD4 T cells enhance primary CD8 T-cell responses. Infect Immun (2007) 0.92
Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization. FASEB J (2006) 0.92
Annexin A2 system in human biology: cell surface and beyond. Semin Thromb Hemost (2013) 0.92
Perforin-mediated CTL cytolysis counteracts direct cell-cell spread of Listeria monocytogenes. J Immunol (2002) 0.92
Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris. Nat Commun (2012) 0.92
Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line. J Lipid Res (2003) 0.92
Identification of murine T-cell epitopes in Ebola virus nucleoprotein. Virology (2004) 0.92